Search Results - "Waldhausen, P"

Refine Results
  1. 1

    Therapy-resistant Ulcera cruris et pedis in ludicrous foot deformity by H.-J. Hermanns, A. Hermanns, P. Waldhausen

    Published in Phlebologie (Stuttgart, Germany) (01-12-2011)
    “…Approximately 90% of all leg and foot ulcers are caused by vasculare diseases. Only 10% have rare pathologies. After a severe accident with deformity and…”
    Get full text
    Journal Article
  2. 2

    Trends in amputations in people with hospital admissions for peripheral arterial disease in Germany by Moysidis, T, Nowack, T, Eickmeyer, F, Waldhausen, P, Brunken, A, Hochlenert, D, Engels, G, Santosa, F, Luther, B, Kröger, K

    Published in VASA (01-07-2011)
    “…Using the information of the federal statistics, a detailed description of the hospitalisation rate for amputation in Germany was possible for the first time,…”
    Get more information
    Journal Article
  3. 3

    Microcirculation and tolerability following i.v. infusion of PGE 1 and iloprost: a randomized cross-over study in patients with critical limb ischemia by Schellong, S, Altmann, E, von Bilderling, P, Rudofsky, G, Waldhausen, P, Rogatti, W

    “…In a randomized cross-over study, the effect of PGE 1 and iloprost on microcirculation as well as the tolerability was investigated in 36 patients with…”
    Get full text
    Journal Article
  4. 4

    Therapierefraktäre Ulcera cruris et pedis bei grotesker Fußdeformität by Hermanns, H.-J., Hermanns, A., Waldhausen, P.

    Published in Phlebologie (Stuttgart, Germany) (2011)
    “…Ulcera der unteren Extremität und des Fußes sind in etwa 90% der Fälle vaskulärer Genese. Nur 10% der Ulcera haben andere, seltene Ursachen. Nach einem…”
    Get full text
    Journal Article
  5. 5

    Chronic wound treatment in elderly and geriatric patients by Hermanns, H.-J., Waldhausen, P.

    Published in Phlebologie (Stuttgart, Germany) (01-07-2017)
    “…Summary In Germany, there has been a continuous increase in life expectancy for more than 135 years. The number of people aged 80 years and over will triple…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Control of therapy with microcirculatory and phlebotropically active drugs in patients with congenital and acquired venous insufficiency by Wenzel, E, Birkel, L, Scheffler, P, Waldhausen, P, Jung, F

    Published in International angiology (01-01-1989)
    “…During the treatment of two patients with Klippel-Trenaunay syndrome interesting observations of the efficacy and the side effects of DHE were made. This led…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia by SCHELLONG, S, ALTMANN, E, VON BILDERLING, P, RUDOFSKY, G, WALDHAUSEN, P, ROGATTI, W

    “…In a randomized cross-over study, the effect of PGE(1) and iloprost on microcirculation as well as the tolerability was investigated in 36 patients with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    getABI: German epidemiological trial on ankle brachial index for elderly patients in family practice to dedect peripheral arterial disease, significant marker for high mortality

    Published in VASA (01-11-2002)
    “…Peripheral arterial occlusive disease (PAD) is a common, but widely underestimated disease associated with a high morbidity and mortality risk. PAD can be…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Die Shave-Therapie im Konzept der operativen Behandlung des therapieresistenten Ulcus cruris venosum: Aktuelle Langzeitergebnisse by Hermanns, H.-J., Gallenkemper, G., Kanya, S., Waldhausen, P.

    Published in Phlebologie (Stuttgart, Germany) (2005)
    “…Zusammenfassung Die Shave-Therapie als rein symptomatisches Verfahren in der operativen Behandlung chronisch-venöser Beingeschwüre und hat sich gegen die…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Tetanus-Impfschutz bei Ulcus-cruris-Patienten by Gallenkemper, G., Hermanns, H. J., Hermann, V., Waldhausen, P.

    Published in Phlebologie (Stuttgart, Germany) (01-06-2002)
    “…Zusammenfassung Ziel, Patienten und Methoden: Hinsichtlich Tetanus-Impfstatus wurden 100 konsekutive Patienten aller Altersgruppen mit Ulcus cruris anhand…”
    Get full text
    Journal Article
  16. 16

    Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%) by Jung, F, Waldhausen, P, Spitzer, S, Wenzel, E

    Published in Acta medica Austriaca (1991)
    “…This study was designed to investigate whether the positive effect occurring after infusion of a 10% hydroxyethyl starch solution 200.000/0.62 on cutaneous…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease by Kiesewetter, H, Blume, J, Jung, F, Spitzer, S, Gerhards, M, Waldhausen, P, Wenzel, E

    Published in Wiener medizinische Wochenschrift (15-09-1989)
    “…The basic therapy in stage IIb of peripheral arterial occlusive disease (PAOD) according to Fontaine is exercise. The aim of this study was to test whether…”
    Get more information
    Journal Article
  19. 19

    Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage by Waldhausen, P, Kiesewetter, H, Leipnitz, G, Scielny, J, Jung, F, Bambauer, R, von Blohn, G

    Published in Acta medica Austriaca (1991)
    “…Hemorheological therapy through hemodilution has been gaining importance for several years and been applied to an ever increasing degree in stationary as well…”
    Get more information
    Journal Article
  20. 20

    Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5) by Jung, F, Waldhausen, P, Mrowietz, C, Spitzer, S, Kiesewetter, H, Wenzel, E

    Published in Infusionstherapie (01-08-1989)
    “…In an open study the influence of hypervolemic hemodilution (Infusion of 500 cc hydroxyethyl starch 200,000/0.5 6% within 1 h) on macro- and microcirculation,…”
    Get more information
    Journal Article